参与偏头痛临床管理的主要目标
Rapuru Rushendran1, Vellapandian Chitra1, Kaliappan Ilango2
1Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur- 603 203, Chengalpattu (Dt), Tamil Nadu, India.
Current neurovascular research
|July 25, 2023
概括
研究人员确定了关键的偏头痛目标,如CGRP和PACAP. 从自然生物分子中可能出现新的治疗方法,为副作用的当前药物提供替代品.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛是导致全球残疾的主要原因,影响数百万.
- 确定可靠的偏头痛目标对于有效治疗至关重要.
研究的目的:
- 为了确定主要的分子点,涉及到偏头痛发作病理生理学.
- 探索新型偏头痛药物开发的潜在生物标志物.
主要方法:
- 在专业数据库 (PubMed,EMBASE,DynaMed Plus,Science Direct) 中进行全面的文献搜索.
- 专注于详细介绍偏头痛病理生理学和临床管理的体外和体内研究.
主要成果:
- 素基因相关 (CGRP), pituitary adenylate cyclase-activating polypeptide (PACAP),NOD类受体蛋白3 (NLRP3) 和血清素是关键的神经炎症生物标志物.
- 这些生物标志物有助于大脑血管扩张和 nociceptive 疼痛,偏头痛发作中的中心机制.
结论:
- 偏头痛的生物标志物 (CGRP,PACAP,NLRP3,等等) 已经被发现. 是潜在的药物目标.
- 草药治疗和天然生物分子可能为当前偏头痛药物提供更安全的替代品.
相关概念视频
Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
Analgesia and Pain Management
660
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
660
Management of Insomnia
281
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
281
Hypertension V: Nursing Management
11
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
11
Angina IV: Management
11
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K


